Loading...
The achievement, which has been verified by the World Health Organisation (WHO), was made possible in part through the support of the Reaching the Last Mile Fund (RLMF), a multi-donor fund established in 2017 by President His Highness Sheikh Mohamed bin Zayed Al Nahyan. In partnership with countries and with support from other funders, RLMF aims to accelerate the elimination of two neglected tropical diseases, river blindness and lymphatic filariasis, in Africa and Yemen.
By eliminating river blindness, Niger has created an estimated USD$2.3 billion in economic benefits. The country added more than 17.8 billion working hours as families with river blindness-infected members were able to rejoin the workforce, boosting GDP. Women, who make up a disproportionate percentage of caregivers, have been able to work again and reinvest 90 percent of their earnings in their families and communities. Additionally, young girls treated for river blindness are likely to achieve higher levels of education and higher wages.
Sheikh Theyab bin Mohamed bin Zayed said, “Under the leadership of President His Highness Sheikh Mohamed bin Zayed Al Nahyan, we congratulate Niger on this historic achievement. Today’s announcement reflects decades of effort and persistence by the government and people of Niger to bring an end to river blindness, and is a tangible step towards a healthier future. The UAE is proud to support the global movement to end neglected tropical diseases and to ensure no one is left behind in our pursuit of a healthier and more equitable world.”
The WHO’s verification is the culmination of nearly 50 years of collaboration in West Africa to control or eliminate river blindness. RLMF partnered with Niger’s Ministry of Health to collect and file evidence supporting the claim for the elimination of transmission of this debilitating disease.
RLMF, established in 2017, initially launched with a USD$100 million fund dedicated to eliminating river blindness and lymphatic filariasis in seven countries in Africa and Yemen. Its founders announced in December 2023 an expansion to target USD$500 million in support of eliminating both diseases from Africa and Yemen by 2030.